Perceptive Advisors - CINCOR PHARMA INC ownership

Back to all holdings Add to watchlist

CINCOR PHARMA INC's ticker is and the CUSIP is 17240Y109. A total of 106 filers reported holding CINCOR PHARMA INC in Q4 2022. The put-call ratio across all filers is 2.63 and the average weighting 0.3%.

Links
Filings
Quarter-by-quarter ownership
Perceptive Advisors ownership history of CINCOR PHARMA INC
ValueSharesWeighting
Q4 2022$31,663,034
-70.8%
2,576,325
-22.1%
0.89%
-71.8%
Q3 2022$108,524,000
+148.4%
3,306,649
+42.6%
3.15%
+130.3%
Q2 2022$43,692,000
+7.4%
2,319,1170.0%1.37%
+67.9%
Q1 2022$40,677,000–2,319,117–0.82%–
 Download
Other shareholders
CINCOR PHARMA INC shareholders Q4 2022
NameSharesValueWeighting ↓
5AM Venture Management, LLC 4,937,646$60,683,66916.31%
Sofinnova Investments, Inc. 6,073,949$74,648,8334.43%
Omega Fund Management, LLC 560,985$7,853,7902.65%
GREAT POINT PARTNERS LLC 1,019,153$12,525,3902.46%
venBio Partners LLC 383,390$4,711,8631.46%
Cheyne Capital Management (UK) LLP 67,557$830,2761.45%
SPHERA FUNDS MANAGEMENT LTD. 529,640$6,509,2761.40%
SILVERARC CAPITAL MANAGEMENT, LLC 395,382$4,859,2451.39%
Perceptive Advisors 2,576,325$31,663,0340.89%
AlphaCentric Advisors LLC 70,000$860,3000.85%
View complete list of CINCOR PHARMA INC shareholders